// App-Quantinova.ai

e20043 : The efficacy and safety analysis of sunitinib plus temozolomide therapy in patients with metastatic mucosal melanoma.

Researchers

Presenter

  • Bixia Tang

Principal Investigators

  • Zhihong Chi

  • Chuanliang Cui

  • Yan Kong

  • Li Li Mao

  • Bin Lian

  • Si Ming Li

  • Xuan Wang

  • Xieqiao Yan

  • Jun Guo

  • Lu Si

  • Xi Nan Sheng

Medical Centers

  • Peking University Cancer Hospital & Institute, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mucosal melanoma

Biomarkers

  • B-Raf proto-oncogene, serine/threonine kinase

  • Circulating tumor cells

  • GTPase Nras

Drug/Treatment

  • Temozolomide

  • Sunitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved